Similar articles

• B-1 (CD 5+) B-cells as a marker of immune dysregulation in multiple myeloma.

  MacKenzie MR, Paglieroni TG. MacKenzie MR, et al. Curr Top Microbiol Immunol. 1995;194:51-6. doi: 10.1007/978-3-642-79275-5_7. Curr Top Microbiol Immunol. 1995. PMID: 7534673 No abstract available.
• CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.

  Zandecki M, Facon T, Bernardi F, Izydorczyk V, Dupond L, François M, Reade R, Iaru T, Bauters F, Cosson A. Zandecki M, et al. J Clin Pathol. 1995 Jun;48(6):548-52. doi: 10.1136/jcp.48.6.548. J Clin Pathol. 1995. PMID: 7545187 Free PMC article.
• Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.

  Jensen GS, Belch AR, Kherani F, Mant MJ, Ruether BA, Pilarski LM. Jensen GS, et al. Scand J Immunol. 1992 Dec;36(6):843-53. doi: 10.1111/j.1365-3083.1992.tb03146.x. Scand J Immunol. 1992. PMID: 1281335
• Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.

  Mayo MM, Johns GS. Mayo MM, et al. Contrib Nephrol. 2007;153:44-65. doi: 10.1159/000096760. Contrib Nephrol. 2007. PMID: 17075223 Review.
• Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.

  Milani P, Palladini G, Merlini G. Milani P, et al. Scand J Clin Lab Invest Suppl. 2016;245:S113-8. doi: 10.1080/00365513.2016.1210337. Epub 2016 Jul 28. Scand J Clin Lab Invest Suppl. 2016. PMID: 27467897 Review.